Keith Tapper
Stock Analyst at BMO Capital
Total Price Targets
6
Stocks Covered
3
Sectors
Healthcare
Most Recent
Apr 14, 2025
Stocks Covered by Keith Tapper
Recent Activity
- Apr 14, 2025— Set$16.00price target onNGNE(Neurogene Inc.)
- Nov 19, 2024— Set$45.00price target onNGNE(Neurogene Inc.)
- Nov 12, 2024— Set$60.00price target onNGNE(Neurogene Inc.)
- Aug 14, 2024— Set$5.00price target onTSHA(Taysha Gene Therapies, Inc.)
- Jun 26, 2024— Set$31.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Jun 26, 2024— Set$65.00price target onNGNE(Neurogene Inc.)
Frequently Asked Questions
Who is Keith Tapper?
Keith Tapper is a stock analyst at BMO Capital covering 3 stocks primarily in Healthcare. They have issued 6 price targets since Jun 26, 2024.
What stocks does Keith Tapper cover?
Keith Tapper currently covers 3 stocks, including NGNE, TSHA, ACAD.
What is Keith Tapper's latest price target?
Keith Tapper's most recent price target was $16.00 on NGNE (Neurogene Inc.), set on Apr 14, 2025.
What is Keith Tapper's highest price target?
Keith Tapper's highest issued price target is $65.00 on NGNE, set on Jun 26, 2024.
More Analysts at BMO Capital
Coverage based on publicly published price targets. Not investment advice.